Skip to main content
. 2016 Oct 15;143(20):3763–3773. doi: 10.1242/dev.133967

Fig. 4.

Fig. 4.

No apparent defects in proliferation and neurogenesis of the arcuate neurons in Isl1cko mice. (A,B) Immunohistochemistry with anti-BrdU antibody (A) and ISH for Mash1 (B) were performed on the ARC of control and Isl1cko mice at E12.5. BrdU was intraperitoneally injected to pregnant females 2 h before euthanasia. (C) ISH for Gad1, Gsx1 and Hmx2 on the ARC of control and Isl1cko mice at E14.5 or E18.5. Signal intensity for Gad1 was quantified using ImageJ. (D) ISH with Gad1 performed on the ARC of control and Isl1cko mice at P21. Dashed lines indicate the boundary of the ARC. Signal intensity for Gad1 was quantified using ImageJ. Double arrows indicate area expressing Gad1. (E) Immunohistochemistry with anti-Sox2 antibody performed on the ARC of control and Isl1cko mice at P28. (F) Immunohistochemistry with anti-NeuN antibody was performed on the ARC of control and Isl1cko mice at E16.5 and P15. The number of NeuN+ cells was quantified using ImageJ. Three controls and four mutants were used for all experiments. Scale bars: 100 μm. **P<0.01; Student's t-test. Error bars indicate s.e.m.